secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2026-08-06T21:15:48+00:00
Accession:  0001193125-26-338438
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences upsizes ATM equity facility to $200M; $85M already sold
-------------------------------------------------------------------------

- Filed prospectus supplement for up to $200M in common stock sales under existing ATM agreement with Jefferies.
- Prior supplement for $85M exhausted; $85M in gross proceeds already raised.
- New supplement replaces prior; no further sales under old supplement.
- Legal opinion from WilmerHale attached as Exhibit 5.1.
- Shares registered under existing shelf registration statement (S-3).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526338438/0001193125-26-338438-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526338438/d177624d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-338438

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer